New Date & Place: MedFIT and BioFIT 2020
In the unique context of this year, and to answer the organisation challenges we are facing, MedFIT and BioFIT organisers and their respective Steering Committees have made the decision to postpone MedFIT (the European partnering event for innovation partnerships and investment rounds in the MedTech, Diagnostic and Digital Health sectors) and BioFIT (the leading European partnering event for early-stage deals and investment rounds in the Pharma/Biotech field), and to organise them together.
Now more than ever, our industry needs a framework to meet and interact with international key innovators in order to accelerate innovation in healthcare.
You can count on our commitment to prepare the next editions of MedFIT and BioFIT in the best conditions and to guide you through this new configuration. You can feel fully confident about registering and we look forward to seeing you in Lille in December.
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
As the leading European partnering event, MedFIT provides the ideal environment for academic and industrial actors to build partnerships, to source innovative and competitive early-stage R&D projects, to facilitate the emergence of collaborative projects, to increase licensing opportunities, to obtain funding and to facilitate market access.